• Home
  • WISAM 2018 Webinar Series

WISAM 2018 Webinar Series

  • 20 Jun 2018
  • (CDT)
  • 17 Oct 2018
  • (CDT)
  • 4 sessions
  • 20 Jun 2018, 5:30 PM 6:30 PM (CDT)
  • 18 Jul 2018, 5:30 PM 6:30 PM (CDT)
  • 15 Aug 2018, 5:30 PM 6:30 PM (CDT)
  • 17 Oct 2018, 5:30 PM 6:30 PM (CDT)
  • UnityPoint Health-Meriter, 202 S Park St, Madison WI 53715



Treatment of Substance Use Disorders in Primary Care Webinar Series

Overview: This complimentary, four-part webinar series, funded in part through a Wisconsin Medical Society Foundation grant, provides timely information and updates related to the treatment of substance use disorders. All presenters are local experts with a clear understanding of Wisconsin’s rural issues and barriers to care.

Target audience: Primary care providers in rural areas of Wisconsin who receive little support and education for evidence-based treatment of substance use disorders.

AMA Credit Designation Statement: The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The Wisconsin Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Participation: Online registration is required. Participants may attend any or all of the webinar sessions either in-person (at Meriter Hospital in Madison on the date/time indicated), or through the on-demand webinar option, which will be available online approximately one week after the session has been recorded. 


Part 1: Wednesday, June 20, 2018, 5:30-6:30 pm

Topic: Suboxone 2.0: Beyond the Basics, presented by Ritu Bhatnagar, MD and John Ewing, MD

Learning Objectives: Describe ways to talk non-judgmentally about adherence and sensitive issues related to buprenorphine; Develop strategies for ongoing management of patients on buprenorphine in the primary care setting.

Part 2: Wednesday, July 18, 2018; 5:30-6:30 pm

Topic: Interpretation of Urine Drug Screen, presented by David Galbis-Reig, MD

Learning Objectives: Discuss the history of drug testing and its introduction into clinical practice; Describe the different drug testing matrices and the potential advantages and disadvantages of each in clinical practice; Understand the basics of urine drug testing: What to test, how to test, and in what situations to perform a urine drug screen; Understand the limitations of urine drug testing; Understand how to interpret a positive urine immunoassay and when to obtain confirmatory tests.

Part 3: Wednesday, August 15, 2018, 5:30-6:30 pm

Topic: Treatment of Stimulant Disorder, presented by Mark Lim, MD

Learning Objectives: Discuss appropriate treatment strategies for patients with stimulant disorder; Understand the limitations of combination pharmacotherapies for the management of stimulant disorder. 

Part 4: Wednesday, October 17, 2018; 5:30-6:30 pm

Topic: Treatment of Alcohol Use and Opioid Use Disorder in Pregnancy, presented by Jacquelyn Adams, MD

Learning Objectives: Describe opioid use disorder and alcohol use disorder in pregnancy; Understand risks of withdrawal in pregnancy; Discuss current treatment standards and possible new therapies specific to pregnancy.

Contact WISAM

563 Carter Court, Suite B
Kimberly, WI 54136

Donate Today!

Help fund WISAM
WISAM is funded in part by generous donations from patrons such as yourself.  Click here to make your donation today.  Your donation is tax deductable.

Copyright © 2018 WISAM All rights reserved.  | Terms of Use | Privacy Policy

Powered by Wild Apricot Membership Software